US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Simplify VettaFi Private Credit Strategy ETF

18.77

+0.35461.93%

Post-market: 18.770.00000.00%16:10 EDT

Volume:22

Turnover:431

Market Cap:2.35M

PE:- -

High:18.77

Open:18.41

Low:18.77

Close:18.41

52wk High:25.37

52wk Low:18.35

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.07

T/O Rate:0.02%

Dividend:2.11

Dividend Rate:11.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Co-Diagnostics Highlights PCR Platform and Global Partnerships

Co-Diagnostics partners on blood-based PCR Ebola testing

Co-Diagnostics Tests ReadyGo Tech for PCR Platform

Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Press Release: ABL Diagnostics (abld) Announces the Filing of a Takeover Bid for Integragen

Asset Relay Across Mountains and Seas: The Operational Chronicle of the National Public Institution Asset Redistribution and Sharing Platform

Soekarno-Hatta Set to Welcome Emirates' Giant A380

Shanghai Zj Bio-Tech's Ebola Test Kit Gains WHO Emergency Use Listing

Press Release: ABL Diagnostics

PureCycle, IPL Schoeller Partner to Produce Sustainable Container for Cleveland Kitchen

PureCycle Advances Food-Contact PCR Solutions to Support New Jersey’s 2027 Recycled Content Requirement

Qiagen Expands Digital PCR Portfolio With New Tools

MT Newswires Live

PureCycle, Innovia Films Partner to Successfully Produce White, Cavitated BOPP Film Using PureFive Choice™ Recycled Polypropylene

Evaluating Qiagen (NYSE:QGEN) After New Bundibugyo Ebolavirus Digital PCR Assays Catch Investor Attention

Simply Wall St.

Roche reports developing PCR test for Ebola within six days

PureCycle and StackTeck Successfully Produce Living Hinge Cap Using PureFive® Recycled Polypropylene

Co-Diagnostics announces continued progress in Ebola PCR development program

Press Release: ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026

Perth biotech duo Avicena, Syngenis forge biosecurity shield

The West Australian

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PCR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCR\",,,,,undefined,":{"symbol":"PCR","market":"US","secType":"STK","nameCN":"Simplify VettaFi Private Credit Strategy ETF","latestPrice":18.7661,"timestamp":1789675200000,"preClose":18.4115,"halted":0,"volume":22,"hourTrading":{"tag":"盘后","latestPrice":18.7661,"preClose":18.7661,"latestTime":"16:10 EDT","volume":6,"amount":112.484388,"timestamp":1789675804342,"change":0,"changeRate":0,"amplitude":0.002989},"delay":0,"changeRate":0.019259701816799358,"floatShares":125001,"shares":125001,"eps":0,"marketStatus":"Post-Mkt","change":0.3546,"latestTime":"09-17 19:50:58 EDT","open":18.4115,"high":18.7661,"low":18.7661,"amount":431,"amplitude":0,"askPrice":23.34,"askSize":100,"bidPrice":14.04,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"listingDate":1758600000000,"exchange":"ARCA","adjPreClose":18.4115,"sharesOutstanding":100001,"nav":18.4231,"aum":2301429.46,"dividendRate":0.112437,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":18.7661,"preClose":18.7661,"latestTime":"16:10 EDT","volume":6,"amount":112.484388,"timestamp":1789675804342,"change":0,"changeRate":0,"amplitude":0.002989},"volumeRatio":0.068111},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCR\",,,,,undefined,":{"symbol":"PCR","floatShares":125001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.068111,"shares":125001,"dividePrice":2.11,"high":18.7661,"amplitude":0,"preClose":18.4115,"low":18.7661,"week52Low":18.35,"pbRate":"--","week52High":25.37,"institutionHeld":0,"latestPrice":18.7661,"eps":0,"divideRate":0.112437,"volume":22,"delay":0,"ttmEps":0,"open":18.4115,"prevYearClose":23.0081,"prevWeekClose":18.69,"prevMonthClose":19.654,"prevQuarterClose":19.5231,"fiveDayClose":18.6477,"twentyDayClose":19.7673,"sixtyDayClose":19.2198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCR\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"PCR","amount":0.19,"announcedDate":"2026-08-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-26","defaultRemindTime":1787751000000,"name":"Simplify VettaFi Private Credit Strategy ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-31","payableDate":"2026-08-26","currency":"USD","dateTimestamp":1787716800000,"payDate":"2026-08-31"},{"date":"2026-07-28","symbol":"PCR","amount":0.19,"announcedDate":"2026-07-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-28","defaultRemindTime":1785245400000,"name":"Simplify VettaFi Private Credit Strategy ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-28","currency":"USD","dateTimestamp":1785211200000,"payDate":"2026-07-31"},{"date":"2026-06-25","symbol":"PCR","amount":0.19,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"Simplify VettaFi Private Credit Strategy ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-05-26","symbol":"PCR","amount":0.19,"announcedDate":"2026-05-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-26","defaultRemindTime":1779802200000,"name":"Simplify VettaFi Private Credit Strategy ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-26","currency":"USD","dateTimestamp":1779768000000,"payDate":"2026-05-29"},{"date":"2026-04-27","symbol":"PCR","amount":0.19,"announcedDate":"2026-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-27","defaultRemindTime":1777296600000,"name":"Simplify VettaFi Private Credit Strategy ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-27","currency":"USD","dateTimestamp":1777262400000,"payDate":"2026-04-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCR\",market:\"US\",,,undefined,":[{"executeDate":"2025-10-28","recordDate":"2025-10-28","paymentDate":"2025-10-31","value":0.06,"currency":"USD"},{"executeDate":"2025-11-21","recordDate":"2025-11-21","paymentDate":"2025-11-28","value":0.24,"currency":"USD"},{"executeDate":"2026-01-27","recordDate":"2026-01-27","paymentDate":"2026-01-30","value":0.24,"currency":"USD"},{"executeDate":"2026-02-24","recordDate":"2026-02-24","paymentDate":"2026-02-27","value":0.2,"currency":"USD"},{"executeDate":"2026-03-26","recordDate":"2026-03-26","paymentDate":"2026-03-31","value":0.19,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667984749","title":"Co-Diagnostics Highlights PCR Platform and Global Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2667984749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667984749?lang=en_us&edition=fundamental","pubTime":"2026-09-16 23:35","pubTimestamp":1789572900,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Co-Diagnostics ( ($CODX) ). On September 16, 2026, Co-Diagnostics, Inc. plans to host an investor and analyst p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/co-diagnostics-highlights-pcr-platform-and-global-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/co-diagnostics-highlights-pcr-platform-and-global-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667083981","title":"Co-Diagnostics partners on blood-based PCR Ebola testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2667083981","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667083981?lang=en_us&edition=fundamental","pubTime":"2026-09-16 22:59","pubTimestamp":1789570754,"startTime":"0","endTime":"0","summary":"Co-Diagnostics ( ($CODX) ) has issued an update. On September 16, 2026, Co-Diagnostics and ReadyGo Diagnostics announced a collaboration to evaluat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/co-diagnostics-partners-on-blood-based-pcr-ebola-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/co-diagnostics-partners-on-blood-based-pcr-ebola-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667228066","title":"Co-Diagnostics Tests ReadyGo Tech for PCR Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2667228066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667228066?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:34","pubTimestamp":1789504442,"startTime":"0","endTime":"0","summary":"An announcement from Co-Diagnostics ( ($CODX) ) is now available. In August 2026, Co-Diagnostics entered into a material transfer agreement with Re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/co-diagnostics-tests-readygo-tech-for-pcr-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/co-diagnostics-tests-readygo-tech-for-pcr-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140666287","title":"Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1140666287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140666287?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:06","pubTimestamp":1789473999,"startTime":"0","endTime":"0","summary":"Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","IEIH","BK1583","PCR","RSPH","HART","MDEV","09996","LGHT","688426","AGNG","159883","BK1100","BK0239","BK1574","LNGR","MEDX","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666523704","title":"Press Release: ABL Diagnostics (abld) Announces the Filing of a Takeover Bid for Integragen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666523704","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666523704?lang=en_us&edition=fundamental","pubTime":"2026-09-11 18:01","pubTimestamp":1789120860,"startTime":"0","endTime":"0","summary":"--  SARS-CoV-2, Tuberculosis, Hepatitis B and C -- Advanced Detection. --  Microbiome and taxonomy -- 16s/18s RNA-based analyses.--  Other viral and bacterial targets -- Comprehensive m","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4156","PCR","BK4232","BK4022","R","ABLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165374559","title":"Asset Relay Across Mountains and Seas: The Operational Chronicle of the National Public Institution Asset Redistribution and Sharing Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1165374559","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165374559?lang=en_us&edition=fundamental","pubTime":"2026-09-09 15:22","pubTimestamp":1788938521,"startTime":"0","endTime":"0","summary":"A batch of training equipment, idle for three years, has finally found a new home. In October 2025, through the National Public Institution Asset Redistribution and Sharing Platform (hereinafter...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655355611","title":"Soekarno-Hatta Set to Welcome Emirates' Giant A380","url":"https://stock-news.laohu8.com/highlight/detail?id=2655355611","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655355611?lang=en_us&edition=fundamental","pubTime":"2026-07-31 12:54","pubTimestamp":1785473684,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Soekarno-Hatta International Airport, operated under InJourney Airports , is set to welcome the inaugural landing of Emirates Airlines' Airbus A380-800, which will operate flight EK358 from Dubai  to Jakarta .Soekarno-Hatta International Airport General Manager Heru Karyadi stated that the world's largest passenger airliner is scheduled to touch down in Jakarta on August 8, 2026, at 10:25 p.m. Jakarta time  before making its return journey to Dubai as flight EK359 on August 9, 2026, at 12:45 a.m. WIB.\"The arrival of the Airbus A380-800 is a major milestone in expanding Indonesia's international air connectivity,\" Heru said on Friday, July 31, 2026.","market":"sg","thumbnail":"https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["DXB","BK7501","DXB.AU","BK7067","BK7508","PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152414370","title":"Shanghai Zj Bio-Tech's Ebola Test Kit Gains WHO Emergency Use Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1152414370","media":"Stock News","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152414370?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:13","pubTimestamp":1783332818,"startTime":"0","endTime":"0","summary":"Shanghai Zj Bio-Tech Co.,Ltd. (ASX: 688317) has announced that its Ebola virus nucleic acid detection kit (using fluorescent PCR methodology) has been included in the World Health Organization's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCR","688317","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648813786","title":"Press Release: ABL Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2648813786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648813786?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:00","pubTimestamp":1783008000,"startTime":"0","endTime":"0","summary":"WOIPPY, France----July 02, 2026--Regulatory News:At the Annual General Meeting of ABL Diagnostics  held on Tuesday, June 30, 2026, at 11:00 a.m., shareholders approved all resolutions submitted for their vote, including the payment of a dividend of EUR0.11 per share for the 2025 fiscal year , reflecting the Company's improved results and strong financial position.The dividend will be ex-dividend on July 3, 2026, and will be paid on July 7, 2026.About ABL Diagnostics ABL Diagnostics  is an international company that specializes in innovative molecular biology tests and global solutions for its customers:--  Molecular polymerase chain reaction  detection -- UltraGene, and. --  Genotyping by DNA sequencing -- DeepChek.ABL Diagnostics markets its entire product range globally through its own sales team and a network of exclusive distributors active on all continents. ABL Diagnostics' customers are academic clinical pathology laboratories, private reference laboratories and researchers will","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","ABLD","R","PCR","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645362608","title":"PureCycle, IPL Schoeller Partner to Produce Sustainable Container for Cleveland Kitchen","url":"https://stock-news.laohu8.com/highlight/detail?id=2645362608","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645362608?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:30","pubTimestamp":1782217800,"startTime":"0","endTime":"0","summary":"Polypropylene container features 25% PureFive recycled polypropylene and will be on store shelves this monthORLANDO, Fla., June  23, 2026  (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/23/3315959/0/en/PureCycle-IPL-Schoeller-Partner-to-Produce-Sustainable-Container-for-Cleveland-Kitchen.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4234","SG9999002224.SGD","LU1280957306.USD","IE00BBT3K403.USD","EPR","BK4588","SG9999014542.SGD","LU0868494708.USD","LU0942090050.USD","BK4504","BK4559","SG9999002232.USD","IE00BKDWB100.SGD","LU0098860793.USD","LU1066051498.USD","LU0689626769.HKD","LU1868837136.USD","LU1929549753.HKD","BK4581","LU2552382215.SGD","LU0237698245.USD","GB00BDT5M118.USD","IE000M9KFDE8.USD","PG","LU1868836757.USD","LU0868494617.USD","BK4018","LU1868836914.USD","LU2129689514.USD","LU2552382132.HKD","LU0094547139.USD","BK4550","SG9999001440.SGD","SG9999014559.SGD","IE00BLSP4239.USD","IE00BWXC8680.SGD","LU0323591593.USD","LU0061475181.USD","LU1585245621.USD","LU2097829019.USD","LU2129689605.HKD","LU2242646821.SGD","BK4084","LU1066053197.SGD","PCR","LU0096364046.USD","BK4534","LU2242652126.USD","LU1914381329.SGD","BK4558"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644982757","title":"PureCycle Advances Food-Contact PCR Solutions to Support New Jersey’s 2027 Recycled Content Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2644982757","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644982757?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:00","pubTimestamp":1781643600,"startTime":"0","endTime":"0","summary":"Food-contact packaging with at least 20% PureFive resin demonstrates a scalable path to compliance as recycled content mandates accelerateORLANDO, Fla., June  16, 2026  (GLOBE NEWSWIRE) -- PureCycle T","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3313073/0/en/PureCycle-Advances-Food-Contact-PCR-Solutions-to-Support-New-Jersey-s-2027-Recycled-Content-Requirement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014542.SGD","IE000M9KFDE8.USD","LU1868836591.USD","BK4567","BK4588","LU1868836914.USD","LU2129689605.HKD","SG9999014567.USD","SG9999015358.SGD","BK4533","BK4585","LU1868836757.USD","LU1868837300.USD","LU0094547139.USD","LU2129689431.USD","LU0689626769.HKD","PG","SG9999002232.USD","LU1585245621.USD","LU1066051498.USD","PCR","LU0868494708.USD","BK4534","IE00BKDWB100.SGD","LU2242646821.SGD","LU0640476718.USD","SG9999001440.SGD","LU1162221912.USD","IE00BWXC8680.SGD","IE00B1XK9C88.USD","LU2552382215.SGD","IE00BBT3K403.USD","LU0234572021.USD","LU0098860793.USD","LU2129689514.USD","LU1066053197.SGD","BK4559","IE00B3T34201.USD","LU0234570918.USD","BK4504","BK4550","BK4558","LU2097829019.USD","LU1914381329.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0096364046.USD","LU2242652126.USD","BK4018","LU0237698245.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643735762","title":"Qiagen Expands Digital PCR Portfolio With New Tools","url":"https://stock-news.laohu8.com/highlight/detail?id=2643735762","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643735762?lang=en_us&edition=fundamental","pubTime":"2026-06-15 15:34","pubTimestamp":1781508880,"startTime":"0","endTime":"0","summary":"Qiagen  said Monday it expanded its digital PCR technology network with updated gene expression tools and automated analysis features to support broader adoption in the sector.The company plans to introduce advanced testing assays later this year alongside a high multiplex kit capable of analyzing up to 12 RNA targets simultaneously, the company said.The group expanded its cell and gene therapy quality control offerings to cover additional host-cell systems while partnering with Hamilton to automate laboratory processes, Qiagen said.The update introduces an evaluation program called QIAcuity Software 3.5, designed to standardize data interpretation and automated reporting, it said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1923622614.USD","LU2125909247.SGD","PCR","LU2433249047.HKD","QGEN","LU2125909593.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642622214","title":"PureCycle, Innovia Films Partner to Successfully Produce White, Cavitated BOPP Film Using PureFive Choice™ Recycled Polypropylene","url":"https://stock-news.laohu8.com/highlight/detail?id=2642622214","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642622214?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:45","pubTimestamp":1781005500,"startTime":"0","endTime":"0","summary":"Milestone Demonstrates Viability ofPureCycle’sRecycled Resin in High-Performance Flexible Packaging for Snack, Confectionery and Roll-Fed Label ApplicationsORLANDO, Fla., June  09, 2026  (GLOBE NEWSWI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308738/0/en/PureCycle-Innovia-Films-Partner-to-Successfully-Produce-White-Cavitated-BOPP-Film-Using-PureFive-Choice-Recycled-Polypropylene.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPR","BK4084","BK4142","PCR","BK4234","CHH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641121360","title":"Evaluating Qiagen (NYSE:QGEN) After New Bundibugyo Ebolavirus Digital PCR Assays Catch Investor Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2641121360","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641121360?lang=en_us&edition=fundamental","pubTime":"2026-06-06 17:14","pubTimestamp":1780737255,"startTime":"0","endTime":"0","summary":"Why Qiagen’s new Bundibugyo ebolavirus assays caught the market’s attention\nQiagen (QGEN) recently announced research use digital PCR assays for Bundibugyo ebolavirus, and the stock rose 3.0% on June 4, 2026, as investors weighed this product launch.\nThe new assays are designed for the QIAcuity digital PCR system and target nucleoprotein and VP35 regions using publicly available outbreak genomic data. This development reinforces Qiagen’s role in infectious disease research workflows.\nSee our...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-qgen/qiagen/news/evaluating-qiagen-nyseqgen-after-new-bundibugyo-ebolavirus-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-qgen/qiagen/news/evaluating-qiagen-nyseqgen-after-new-bundibugyo-ebolavirus-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NYSE","LU2125909593.SGD","BK4121","LU2125909247.SGD","QGEN","LU2433249047.HKD","LU1923622614.USD","PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640681166","title":"Roche reports developing PCR test for Ebola within six days","url":"https://stock-news.laohu8.com/highlight/detail?id=2640681166","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640681166?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:40","pubTimestamp":1780587615,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it developed a Research Use Only molecular PCR test, via its subsidiary TIB MOLBIOL, for use on the LightCycler 480 I ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-reports-developing-pcr-test-for-ebola-within-six-days-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-reports-developing-pcr-test-for-ebola-within-six-days-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","03165","PCR","RHHBY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640490469","title":"PureCycle and StackTeck Successfully Produce Living Hinge Cap Using PureFive® Recycled Polypropylene","url":"https://stock-news.laohu8.com/highlight/detail?id=2640490469","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640490469?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:30","pubTimestamp":1780489800,"startTime":"0","endTime":"0","summary":"Collaboration Demonstrates High-Performance Functionality of PureFive Resin in Demanding Caps & Closures ApplicationsORLANDO, Fla., June  03, 2026  (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Na","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/03/3306046/0/en/PureCycle-and-StackTeck-Successfully-Produce-Living-Hinge-Cap-Using-PureFive-Recycled-Polypropylene.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","BK4534","LU1868836914.USD","LU0320765646.SGD","LU2129689514.USD","LU2129689431.USD","LU2242652126.USD","PG","IE000M9KFDE8.USD","LU1162221912.USD","SG9999002232.USD","LU0096364046.USD","SG9999014567.USD","IE00BWXC8680.SGD","LU0061475181.USD","LU1066053197.SGD","SG9999015341.SGD","IE00BN8TJ469.HKD","LU0234570918.USD","LU1585245621.USD","LU1914381329.SGD","IE00BLSP4452.SGD","LU0323591593.USD","LU0098860793.USD","BK4559","SG9999014542.SGD","BK4558","LU2129689605.HKD","SG9999014559.SGD","GB00BDT5M118.USD","SG9999015358.SGD","PCR","BK4504","BK4533","LU1868837300.USD","IE00B1XK9C88.USD","LU0124676726.USD","LU0868494617.USD","BK4581","LU0234572021.USD","LU0689626769.HKD","BK4585","LU0094547139.USD","LU1280957306.USD","LU1868837136.USD","SG9999002224.SGD","LU2097829019.USD","LU2242646821.SGD","BK4567","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941417","title":"Co-Diagnostics announces continued progress in Ebola PCR development program","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640941417?lang=en_us&edition=fundamental","pubTime":"2026-06-02 22:52","pubTimestamp":1780411938,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) announced continued progress in its Ebola PCR development program with joint venture CoSara Diagnostics. The program includes...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-announces-continued-progress-in-ebola-pcr-development-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-announces-continued-progress-in-ebola-pcr-development-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CODX","PCR","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640963269","title":"Press Release: ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640963269","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640963269?lang=en_us&edition=fundamental","pubTime":"2026-06-02 00:06","pubTimestamp":1780329960,"startTime":"0","endTime":"0","summary":"--  Full-year 2026 revenue target set at EUR12.27 million, delivering an. --  Historic shift in scale driven by the full-year impact of growth. \"The consolidated operational indicators for the 2026 fiscal year confirm a historic shift in scale for ABL Diagnostics. With a revenue target of EUR12.27 million, representing growth of over 76%, we are reaping the benefits of the technology integration strategy initiated in 2025. The remarkable performance of the UltraGene range , combined with the massive contribution of our exclusive distribution agreements with Vela Diagnostics and CDL Pharma, validates our business model as a global player in in vitro diagnostics,\" stated Dr. Chalom Sayada, CEO of ABL Diagnostics. \"Our strong commercial visibility and the recurrence of our business workflows allow us to confirm this full-year trajectory with high confidence.\". 2026 Revenue Targets and Outlook by Business Segment. Based on its commercial management roadmap derived from underlying operation","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCR","ABLD","BK4022","BK4232","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638522106","title":"Perth biotech duo Avicena, Syngenis forge biosecurity shield","url":"https://stock-news.laohu8.com/highlight/detail?id=2638522106","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638522106?lang=en_us&edition=fundamental","pubTime":"2026-05-27 01:36","pubTimestamp":1779817005,"startTime":"0","endTime":"0","summary":"Perth biotechs Avicena Systems and Syngenis Laboratories are teaming up to fast-track high-volume pathogen detection technology aimed at protecting Australia’s agriculture, trade and health systems.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22343028/f130c1f262988f4d29662c1112691d02df134b9b.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22343028/f130c1f262988f4d29662c1112691d02df134b9b.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/perth-biotech-duo-avicena-syngenis-forge-biosecurity-shield-c-22343028","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/perth-biotech-duo-avicena-syngenis-forge-biosecurity-shield-c-22343028","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["SLF.AU","VAP.AU","ZYAU.AU","VAS.AU","PCR","IIGF.AU","IOZ.AU","BBOZ.AU","E200.AU","XKO.AU","STW.AU","XJO.AU","OZR.AU","GIVE.AU","DACE.AU","OZF.AU","IISV.AU","IMLC.AU","GEAR.AU","EIGA.AU","QFN.AU","BEAR.AU","QRE.AU","XAO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638548204","title":"Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development","url":"https://stock-news.laohu8.com/highlight/detail?id=2638548204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638548204?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:04","pubTimestamp":1779804286,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (CODX) announced that it has advanced the PCR assay development strategy for the Bundibugyo virus, or BDBV, currently causing an out...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/co-diagnostics-and-cosara-diagnostics-advance-with-ebola-pcr-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/co-diagnostics-and-cosara-diagnostics-advance-with-ebola-pcr-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CODX","BK4082","BK4568","PCR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}